- Letter
- Published:
Removal of phosphorylation sites from the β2-adrenergic receptor delays onset of agonist-promoted desensitization
- Michel Bouvier1,
- William P. Hausdorff1,
- Antonio De Blasi1,
- Brian F. O'Dowd1,
- Brian K. Kobilka1,
- Marc G. Caron1 &
- …
- Robert J. Lefkowitz1
Naturevolume 333, pages370–373 (1988)Cite this article
961Accesses
3Altmetric
Abstract
Eukaryotic cells have evolved a variety of mechanisms for dampening their responsiveness to hormonal stimulation in the face of sustained activation. The mechanisms for such processes, collectively referred to as desensitization, often involve alterations in the properties and number of cell-surface hormone receptors1–3. It has been speculated that phosphorylation–dephosphorylation reactions, which are known to regulate the catalytic activities of enzymes, also regulate the function of receptors4. Highly specific receptor kinases, such as rhodopsin kinase5 and β-adrenergic receptor kinase6, which show stimulus-dependent phosphorylation of receptors have been described. Direct evidence for a causal relationship between receptor phosphorylation and desensitization has been lacking however. Here we report that prevention of agonist-stimulated β2-adrenergic receptor (β2AR) phosphorylation by truncation of its serine and threonine-rich phosphate acceptor segment delays the onset of desensitization. We also show that selective replacement of these serine and theronine residues by alanine and glycine delays desensitization even further. These data provide the first direct evidence that one molecular mechanism of desensitization of G-protein-coupled receptors involves their agonist-induced phosphorylation.
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Harden, T. K.Pharmac. Rev.35, 5–23 (1983).
Clark, R. B.Adv. Cyclic Nucleotide Res.20, 155–209 (1986).
Sibley, D. R. & Lefkowitz, R. J.Nature317, 124–129 (1985).
Sibley, D. R., Benovic, J. L., Caron, M. G. & Lefkowitz, R. J.Cell48, 913–922 (1987).
Kuhn, H. & Dreyer, W. J.FFBS Lett.20, 1–6 (1972).
Benovic, J. L., Strasser, R. H., Caron, M. G. & Lefkowitz, R. J.Proc. natn. Acad. Sci. U.S.A.83, 2797–2801 (1986).
Dixon, R. A. F.et al.Nature321, 75–79 (1986).
Dohlman, H. G., Bouvier, M., Benovic, J. L., Caron, M. G. & Lefkowitz, R. J.J. biol. Chem.262, 14282–14288 (1987).
Henderson, R. & Umwin, P. N. T.Nature257, 28–32 (1975).
Hargrave, P. A.et al.Neurochem. Int.1, 231–244 (1980).
Thompson, P. & Findlay, J. B. C.Biochem. J.220, 773–780 (1984).
Miller, J. L. & Dratz, E. A.Vision Res.24, 1509–1521 (1984).
Bouvier, M.et al.Molec. Pharmac.33, 133–139 (1988).
Homburger, V.et al.J. biol. Chem.255, 10436–10444 (1980).
Waldo, G. L., Northup, A. J. K., Perkins, J. P. & Harden, T. K.J. biol. Chem.258, 13900–13908 (1983).
Strader, C. D.et al.Cell49, 855–863 (1987).
Benovic, J. L.et al.Proc. natn. Acad. Sci. U.S.A.24, 8879–8882 (1987).
Huganir, R. L., Delcour, A. H., Greengard, P. & Hess, G. P.Nature321, 774–776 (1986).
Kobilka, B. K.et al.J. biol. Chem.262, 7321–7327 (1987).
Cullen, B.Meth. Enzym.152, 684 (1987).
Gorman, C. inDNA cloning, A Practical Approach Vol.II. (ed. Glover, D. M.) 143–290 (IRL Press, Oxford, 1985).
Laemmli, U. K.Nature227, 680–686 (1970).
Shorr, R. G. L., Lefkowitz, R. J. & Caron, M. G.J. biol. Chem.256, 5820–5826 (1981).
Salomon, Y., Londos, C. & Rodbell, M.Analyt. Biochem.58, 541–548 (1974).
DeBlasi, A., Lipartiti, M., Motulsky, S., Insel, P. A. & Fratelli, M.J. clin. Endocr. Metab.61, 1081–1088 (1985).
Author information
Authors and Affiliations
Howard Hughes Medical Institute Laboratories, Departments of Physiology, Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina, 27710, USA
Michel Bouvier, William P. Hausdorff, Antonio De Blasi, Brian F. O'Dowd, Brian K. Kobilka, Marc G. Caron & Robert J. Lefkowitz
- Michel Bouvier
You can also search for this author inPubMed Google Scholar
- William P. Hausdorff
You can also search for this author inPubMed Google Scholar
- Antonio De Blasi
You can also search for this author inPubMed Google Scholar
- Brian F. O'Dowd
You can also search for this author inPubMed Google Scholar
- Brian K. Kobilka
You can also search for this author inPubMed Google Scholar
- Marc G. Caron
You can also search for this author inPubMed Google Scholar
- Robert J. Lefkowitz
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Bouvier, M., Hausdorff, W., Blasi, A.et al. Removal of phosphorylation sites from the β2-adrenergic receptor delays onset of agonist-promoted desensitization.Nature333, 370–373 (1988). https://doi.org/10.1038/333370a0
Received:
Accepted:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases
- Teresa R. Kee
- Sophia A. Khan
- Jung-A A. Woo
Experimental & Molecular Medicine (2024)
Molecular mechanism of GPCR-mediated arrestin activation
- Naomi R. Latorraca
- Jason K. Wang
- Ron O. Dror
Nature (2018)
Catalytic activation of β-arrestin by GPCRs
- Kelsie Eichel
- Damien Jullié
- Mark von Zastrow
Nature (2018)
Multiple functions of G protein-coupled receptor kinases
- Kenji Watari
- Michio Nakaya
- Hitoshi Kurose
Journal of Molecular Signaling (2014)
Roles of the α1A-adrenergic receptor carboxyl tail in protein kinase C-induced phosphorylation and desensitization
- Alejandro Cabrera-Wrooman
- María Teresa Romero-Ávila
- J. Adolfo García-Sáinz
Naunyn-Schmiedeberg's Archives of Pharmacology (2010)
